Research Articles
Double-Barrel Attack: Simultaneously Targeting ErbB1 and ErbB2 to Combat Cholangiocarcinoma
Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy
The Silent Killer in the Bile Ducts: How Genetics and Immunotherapy are Revolutionizing Cholangiocarcinoma Treatment
Exploring the genetic and epigenetic factors in cholangiocarcinoma and the latest advancements in immunotherapy treatments.